Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Probiotics and paraprobiotics have the potential to alleviate kidney inflammation by modulating colitis and influencing the autophagy pathway. This study aimed to evaluate their effects on autophagy pathway in kidney inflammation following colitis. Colitis was induced in mice using dextran sodium sulfate (DSS) to simulate gut inflammation. Molecular analysis (qPCR) measured the expression of autophagy-related genes such as beclin, atg5, atg7, atg12, and atg13 in kidney tissue. DSS treatment significantly worsened colitis symptoms, increasing Disease Activity Index (DAI) and pathological scores while reducing colon length and weight. Treatment with probiotics and paraprobiotics improved these parameters and restored colon health. Moreover, DSS reduced autophagy gene expression in kidneys, whereas probiotic treatments significantly upregulated these genes, indicating an autophagy-inducing effect that helps mitigate colitis-associated kidney inflammation.

Download full-text PDF

Source
http://dx.doi.org/10.1093/lambio/ovaf113DOI Listing

Publication Analysis

Top Keywords

kidney inflammation
16
probiotics paraprobiotics
12
inflammation colitis
8
autophagy pathway
8
inflammation
5
colitis
5
targeting kidney
4
colitis role
4
role probiotics
4
autophagy
4

Similar Publications

Background: Chronic kidney disease (CKD) is associated with a higher prevalence of valvular diseases and increased mortality from cardiovascular causes. Factors that influence the genesis of cardiac valve calcification (CVC) in these patients are not well-defined.

Objective: To determine the risk factors for valvular calcification in patients with CKD.

View Article and Find Full Text PDF

Chronic diarrhea is a frequent gastrointestinal complication in both type 1 (T1D) and type 2 diabetes (T2D), although the underlying mechanisms differ: T1D is linked to autonomic neuropathy and disrupted transporter regulation, while T2D is often linked to medications and intestinal inflammation. Using streptozotocin-induced mouse models of T1D and T2D, we observed increased luminal fluid in the small intestine of both. Given the role of Na⁺/H⁺ exchanger 3 (NHE3) in fluid absorption and its loss in most diarrheal diseases, we examined NHE3 expression across intestinal segments.

View Article and Find Full Text PDF

Do psycho-behavioural interventions improve mental and physical health in chronic kidney disease? A systematic review of randomised controlled trials.

J Nephrol

September 2025

Department of Psychology, Institute of Psychiatry, Psychology & Neuroscience, Health Psychology Section, King's College London, 5th Floor Bermondsey Wing, Guy's Campus, London Bridge, London, SE1 9RT, UK.

Background: Depression and anxiety are common in chronic kidney disease (CKD) and worsen clinical outcomes. Psycho-behavioural interventions offer a promising, non-pharmacological approach. However, most evidence comes from people with kidney failure with distinct treatment needs, limiting relevance to earlier stages of CKD, where timely support may enhance self-management and slow progression.

View Article and Find Full Text PDF

Cardiovascular-Kidney-Metabolic (CKM) syndrome, a newly defined systemic disorder, is characterized by the pathological interplay among diabetes, chronic kidney disease (CKD), and cardiovascular disease (CVD). Recent studies have identified chronic inflammation not only as a central mediator in the pathological progression of CKM syndrome but also as a pivotal molecular hub that drives coordinated damage across multiple organ systems. Mechanistic investigations have revealed that aberrant activation of signaling pathways such as NF-κB, Wnt, PI3K-AKT, JAK-STAT, and PPAR constitutes a complex inflammatory regulatory network.

View Article and Find Full Text PDF

Background And Aims: Fulminant myocarditis (FM) is a complex clinical syndrome characterized by acute myocardial inflammation and cardiogenic shock. Evidence on long-term outcomes, mortality risk factors, and targeted treatment options remains limited.

Methods: This retrospective analysis included consecutive adult patients admitted for FM between January 2012 and November 2022 at 26 European tertiary centres.

View Article and Find Full Text PDF